BridgeBio Pharma (BBIO) Shareholder's Equity (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.08 Bn |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | -2.27 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.27 Bn |
| Dec 31, 2025 | -2.09 Bn |
| Sep 30, 2025 | -1.93 Bn |
| Jun 30, 2025 | -1.78 Bn |
| Mar 31, 2025 | -1.64 Bn |
| Dec 31, 2024 | -1.46 Bn |
| Sep 30, 2024 | -1.22 Bn |
| Jun 30, 2024 | -1.08 Bn |
| Mar 31, 2024 | -1.04 Bn |
| Dec 31, 2023 | -1.34 Bn |
| Sep 30, 2023 | -1.20 Bn |
| Jun 30, 2023 | -1.35 Bn |
| Mar 31, 2023 | -1.21 Bn |
| Dec 31, 2022 | -1.24 Bn |
| Sep 30, 2022 | -1.13 Bn |
| Jun 30, 2022 | -1.01 Bn |
| Mar 31, 2022 | -1.04 Bn |
| Dec 31, 2021 | -867.00 Mn |
| Sep 30, 2021 | -738.84 Mn |
| Jun 30, 2021 | -457.49 Mn |
| Mar 31, 2021 | -389.37 Mn |
| Dec 31, 2020 | 106.26 Mn |
| Sep 30, 2020 | 215.81 Mn |
| Jun 30, 2020 | 325.61 Mn |
| Mar 31, 2020 | 449.02 Mn |
| Dec 31, 2019 | 473.73 Mn |
| Sep 30, 2019 | 521.70 Mn |
| Jun 30, 2019 | 211.32 Mn |
| Mar 31, 2019 | 310.46 Mn |
| Dec 31, 2018 | 377.24 Mn |
| Sep 30, 2018 | 165.88 Mn |
| Jun 30, 2018 | 204.37 Mn |
| Dec 31, 2017 | 88.35 Mn |